213 related articles for article (PubMed ID: 23065599)
1. Requirement for stromal estrogen receptor alpha in cervical neoplasia.
Chung SH; Shin MK; Korach KS; Lambert PF
Horm Cancer; 2013 Feb; 4(1):50-9. PubMed ID: 23065599
[TBL] [Abstract][Full Text] [Related]
2. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
[TBL] [Abstract][Full Text] [Related]
3. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.
Son J; Park JW; Lambert PF; Chung SH
Carcinogenesis; 2014 Feb; 35(2):489-96. PubMed ID: 24148821
[TBL] [Abstract][Full Text] [Related]
4. Epithelial oestrogen receptor α is dispensable for the development of oestrogen-induced cervical neoplastic diseases.
Son J; Park Y; Chung SH
J Pathol; 2018 Jun; 245(2):147-152. PubMed ID: 29532467
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.
Spurgeon ME; den Boon JA; Horswill M; Barthakur S; Forouzan O; Rader JS; Beebe DJ; Roopra A; Ahlquist P; Lambert PF
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9076-E9085. PubMed ID: 29073104
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice.
Park JS; Rhyu JW; Kim CJ; Kim HS; Lee SY; Kwon YI; Namkoong SE; Sin HS; Um SJ
Gynecol Oncol; 2003 Jun; 89(3):360-8. PubMed ID: 12798696
[TBL] [Abstract][Full Text] [Related]
7. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.
den Boon JA; Pyeon D; Wang SS; Horswill M; Schiffman M; Sherman M; Zuna RE; Wang Z; Hewitt SM; Pearson R; Schott M; Chung L; He Q; Lambert P; Walker J; Newton MA; Wentzensen N; Ahlquist P
Proc Natl Acad Sci U S A; 2015 Jun; 112(25):E3255-64. PubMed ID: 26056290
[TBL] [Abstract][Full Text] [Related]
8. Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
Hong MK; Wang JH; Su CC; Li MH; Hsu YH; Chu TY
Int J Gynecol Cancer; 2017 Jul; 27(6):1247-1255. PubMed ID: 28472813
[TBL] [Abstract][Full Text] [Related]
9. Progesterone signaling inhibits cervical carcinogenesis in mice.
Yoo YA; Son J; Mehta FF; DeMayo FJ; Lydon JP; Chung SH
Am J Pathol; 2013 Nov; 183(5):1679-1687. PubMed ID: 24012679
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of cervical cancer in mice after selective estrogen receptor modulator therapy.
Spurgeon ME; Chung SH; Lambert PF
Am J Pathol; 2014 Feb; 184(2):530-40. PubMed ID: 24418098
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A deficiency in K14E7HPV expressing transgenic mice facilitates the formation of malignant cervical lesions.
Ocadiz-Delgado R; Serafin-Higuera N; Alvarez-Rios E; García-Villa E; Tinajero-Rodríguez M; Rodríguez-Uribe G; Escobar-Wilches DC; Estela Albino-Sánchez M; Ramírez-Rosas A; Sierra-Santoyo A; Hernández-Pando R; Lambert P; Gariglio P
APMIS; 2021 Aug; 129(8):512-523. PubMed ID: 34046932
[TBL] [Abstract][Full Text] [Related]
13. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis.
Ramachandran B
Endocr Relat Cancer; 2017 Apr; 24(4):R99-R108. PubMed ID: 28283546
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis.
Fadiel A; Choi SD; Park B; Kim TH; Buldo-Licciardi J; Ahmadi M; Arslan A; Mittal K; Naftolin F
Reprod Sci; 2017 May; 24(5):706-712. PubMed ID: 27688241
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists.
Chung SH; Lambert PF
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19467-72. PubMed ID: 19901334
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein.
Jabbar SF; Park S; Schweizer J; Berard-Bergery M; Pitot HC; Lee D; Lambert PF
Cancer Res; 2012 Aug; 72(16):4008-16. PubMed ID: 22700879
[TBL] [Abstract][Full Text] [Related]
18. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.
Nair HB; Luthra R; Kirma N; Liu YG; Flowers L; Evans D; Tekmal RR
Cancer Res; 2005 Dec; 65(23):11164-73. PubMed ID: 16322267
[TBL] [Abstract][Full Text] [Related]
19. p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
Shai A; Pitot HC; Lambert PF
Cancer Res; 2008 Apr; 68(8):2622-31. PubMed ID: 18413729
[TBL] [Abstract][Full Text] [Related]
20. Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.
Ogawa M; Hashimoto K; Kitano S; Yamashita S; Toda A; Nakamura K; Kinose Y; Kodama M; Sawada K; Kimura T
Biochem Biophys Res Commun; 2023 Jun; 659():80-90. PubMed ID: 37054506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]